Validity and Reliability of Dual-energy X-ray Absorptiometry for the Assessment of Abdominal Adiposity
Overview
Affiliations
A number of methods exist for the estimation of abdominal obesity, ranging from waist-to-hip ratio to computed tomography (CT). Although dual-energy X-ray absorptiometry (DXA) was originally used to measure bone density and total body composition, recent improvements in software allow it to determine abdominal fat mass. Sixty-five men and women aged 18-72 yr participated in a series of studies to examine the validity and reliability of the DXA to accurately measure abdominal fat. Total body fat and abdominal regional fat were measured by DXA using a Lunar DPX-IQ. Multislice CT scans were performed between L1 and L4 vertebral bodies (region of interest) using a Picker PQ5000 CT scanner, and volumetric analyses were carried out on a Voxel Q workstation. Both abdominal total tissue mass (P = 0.02) and abdominal fat mass (P < 0.0001) in the L1-L4 region of interest were significantly lower as measured by DXA compared with multislice CT. However, Bland-Altman analysis demonstrated good concordance between DXA and CT for abdominal total tissue mass (i.e., limits of agreement = -1.56-2.54 kg) and fat mass (i.e., limits of agreement = -0.40-1.94 kg). DXA also showed excellent reliability among three different operators to determine total, fat, and lean body mass in the L1-L4 region of interest (intraclass correlations, R = 0.94, 0.97, and 0.89, respectively). In conclusion, the DXA L1-L4 region of interest compared with CT proved to be both reliable and accurate method to determine abdominal obesity.
Relationship of female pelvic floor muscle function and body composition: cross-sectional study.
Sousa A, Mattiello S, Driusso P Arch Gynecol Obstet. 2024; 310(6):3297-3303.
PMID: 39601813 DOI: 10.1007/s00404-024-07848-w.
Baglietto N, Vaquero-Cristobal R, Albaladejo-Saura M, Mecherques-Carini M, Esparza-Ros F Front Nutr. 2024; 11:1445892.
PMID: 39224178 PMC: 11366593. DOI: 10.3389/fnut.2024.1445892.
Varney E, Lirette S, Katzmarzyk P, Greenway F, Howard C Clin Obes. 2024; 14(4):e12660.
PMID: 38602005 PMC: 11239286. DOI: 10.1111/cob.12660.
Travers R, Trim W, Motta A, Betts J, Thompson D Int J Obes (Lond). 2024; 48(7):993-1002.
PMID: 38538853 PMC: 11216992. DOI: 10.1038/s41366-024-01513-7.
Korean Nationwide Exploration of Sarcopenia Prevalence and Risk Factors in Late Middle-Aged Women.
Hwang J, Park S Healthcare (Basel). 2024; 12(3).
PMID: 38338247 PMC: 10855089. DOI: 10.3390/healthcare12030362.